These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 22831755)

  • 1. Neuregulin 3 is associated with attention deficits in schizophrenia and bipolar disorder.
    Meier S; Strohmaier J; Breuer R; Mattheisen M; Degenhardt F; Mühleisen TW; Schulze TG; Nöthen MM; Cichon S; Rietschel M; Wüst S
    Int J Neuropsychopharmacol; 2013 Apr; 16(3):549-56. PubMed ID: 22831755
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Temporal, Diagnostic, and Tissue-Specific Regulation of NRG3 Isoform Expression in Human Brain Development and Affective Disorders.
    Paterson C; Wang Y; Hyde TM; Weinberger DR; Kleinman JE; Law AJ
    Am J Psychiatry; 2017 Mar; 174(3):256-265. PubMed ID: 27771971
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuregulin 3 (NRG3) as a susceptibility gene in a schizophrenia subtype with florid delusions and relatively spared cognition.
    Morar B; Dragović M; Waters FA; Chandler D; Kalaydjieva L; Jablensky A
    Mol Psychiatry; 2011 Aug; 16(8):860-6. PubMed ID: 20548296
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deficits in sustained attention in schizophrenia and affective disorders: stable versus state-dependent markers.
    Liu SK; Chiu CH; Chang CJ; Hwang TJ; Hwu HG; Chen WJ
    Am J Psychiatry; 2002 Jun; 159(6):975-82. PubMed ID: 12042186
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Common genetic variation in Neuregulin 3 (NRG3) influences risk for schizophrenia and impacts NRG3 expression in human brain.
    Kao WT; Wang Y; Kleinman JE; Lipska BK; Hyde TM; Weinberger DR; Law AJ
    Proc Natl Acad Sci U S A; 2010 Aug; 107(35):15619-24. PubMed ID: 20713722
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NRG3 contributes to cognitive deficits in chronic patients with schizophrenia.
    Li Z; Liu L; Lin W; Zhou Y; Zhang G; Du X; Li Y; Tang W; Zhang X
    Schizophr Res; 2020 Jan; 215():134-139. PubMed ID: 31753594
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genotype-phenotype studies in bipolar disorder showing association between the DAOA/G30 locus and persecutory delusions: a first step toward a molecular genetic classification of psychiatric phenotypes.
    Schulze TG; Ohlraun S; Czerski PM; Schumacher J; Kassem L; Deschner M; Gross M; Tullius M; Heidmann V; Kovalenko S; Jamra RA; Becker T; Leszczynska-Rodziewicz A; Hauser J; Illig T; Klopp N; Wellek S; Cichon S; Henn FA; McMahon FJ; Maier W; Propping P; Nöthen MM; Rietschel M
    Am J Psychiatry; 2005 Nov; 162(11):2101-8. PubMed ID: 16263850
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bipolar disorder, schizophrenia, and other psychotic disorders in adults with childhood onset AD/HD and/or autism spectrum disorders.
    Stahlberg O; Soderstrom H; Rastam M; Gillberg C
    J Neural Transm (Vienna); 2004 Jul; 111(7):891-902. PubMed ID: 15206005
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Suggestive linkage to chromosomal regions 13q31 and 22q12 in families with psychotic bipolar disorder.
    Potash JB; Zandi PP; Willour VL; Lan TH; Huo Y; Avramopoulos D; Shugart YY; MacKinnon DF; Simpson SG; McMahon FJ; DePaulo JR; McInnis MG
    Am J Psychiatry; 2003 Apr; 160(4):680-6. PubMed ID: 12668356
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mood congruent psychotic symptoms and specific cognitive deficits in carriers of the novel schizophrenia risk variant at MIR-137.
    Cummings E; Donohoe G; Hargreaves A; Moore S; Fahey C; Dinan TG; McDonald C; O'Callaghan E; O'Neill FA; Waddington JL; Murphy KC; Morris DW; Gill M; Corvin A
    Neurosci Lett; 2013 Jan; 532():33-8. PubMed ID: 22982201
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A data-driven investigation of relationships between bipolar psychotic symptoms and schizophrenia genome-wide significant genetic loci.
    Leonenko G; Di Florio A; Allardyce J; Forty L; Knott S; Jones L; Gordon-Smith K; Owen MJ; Jones I; Walters J; Craddock N; O'Donovan MC; Escott-Price V
    Am J Med Genet B Neuropsychiatr Genet; 2018 Jun; 177(4):468-475. PubMed ID: 29671935
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Levels of neuregulin 1 and 3 proteins in Brodmann's area 46 from subjects with schizophrenia and bipolar disorder.
    Boer S; Berk M; Dean B
    Neurosci Lett; 2009 Nov; 466(1):27-9. PubMed ID: 19765633
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bipolar spectrum disorders in patients diagnosed with velo-cardio-facial syndrome: does a hemizygous deletion of chromosome 22q11 result in bipolar affective disorder?
    Papolos DF; Faedda GL; Veit S; Goldberg R; Morrow B; Kucherlapati R; Shprintzen RJ
    Am J Psychiatry; 1996 Dec; 153(12):1541-7. PubMed ID: 8942449
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Operation of the schizophrenia susceptibility gene, neuregulin 1, across traditional diagnostic boundaries to increase risk for bipolar disorder.
    Green EK; Raybould R; Macgregor S; Gordon-Smith K; Heron J; Hyde S; Grozeva D; Hamshere M; Williams N; Owen MJ; O'Donovan MC; Jones L; Jones I; Kirov G; Craddock N
    Arch Gen Psychiatry; 2005 Jun; 62(6):642-8. PubMed ID: 15939841
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neurocognitive functioning as intermediary phenotype and predictor of psychosocial functioning across the psychosis continuum: studies in schizophrenia and bipolar disorder.
    Jabben N; Arts B; van Os J; Krabbendam L
    J Clin Psychiatry; 2010 Jun; 71(6):764-74. PubMed ID: 20122370
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Investigating the association between neurocognition and psychosis in bipolar disorder: further evidence for the overlap with schizophrenia.
    Jabben N; Arts B; Krabbendam L; van Os J
    Bipolar Disord; 2009 Mar; 11(2):166-77. PubMed ID: 19267699
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic variations of human neuropsin gene and psychiatric disorders: polymorphism screening and possible association with bipolar disorder and cognitive functions.
    Izumi A; Iijima Y; Noguchi H; Numakawa T; Okada T; Hori H; Kato T; Tatsumi M; Kosuga A; Kamijima K; Asada T; Arima K; Saitoh O; Shiosaka S; Kunugi H
    Neuropsychopharmacology; 2008 Dec; 33(13):3237-45. PubMed ID: 18354391
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cognitive functioning in schizophrenia and bipolar disorder: comparison of performance on the Repeatable Battery for the Assessment of Neuropsychological Status.
    Dickerson F; Boronow JJ; Stallings C; Origoni AE; Cole SK; Yolken RH
    Psychiatry Res; 2004 Nov; 129(1):45-53. PubMed ID: 15572184
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuregulin 3 does not confer risk for schizophrenia and smooth pursuit eye movement abnormality in a Korean population.
    Pasaje CF; Bae JS; Park BL; Cheong HS; Kim JH; Park TJ; Lee JS; Kim Y; Park CS; Kim BJ; Cha B; Kim JW; Choi WH; Shin TM; Choi IG; Hwang J; Shin HD; Woo SI
    Genes Brain Behav; 2011 Nov; 10(8):828-33. PubMed ID: 21762460
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The genetics of psychotic bipolar disorder.
    Goes FS; Sanders LL; Potash JB
    Curr Psychiatry Rep; 2008 Apr; 10(2):178-89. PubMed ID: 18474212
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.